Practical Aspects of Incorporating CAR T-cell Therapy into Your Practice

Registration



Date:
  Wednesday, June 23, 2021
Time: 7:00 PM - 9:00 PM EDT / 4:00 PM - 6:00 PM PDT

Virtual Symposium Overview
This live-streamed independent satellite symposium will take place following the #ASCO21 Meeting and will be presented on an interactive web platform by 3 renowned experts actively engaged in the use of CAR T-cell therapry for patients with lymphoma and myeloma. 

Target Audience
The target audience for this activity is community and academic medical oncologists, hematologic oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with lymphoma and myeloma.

Learning Objectives
After participating in this activity, participants should be better able to:

  • Incorporate CAR T-cell therapy into their clinical practice, and identify appropriate patients
  • Develop strategies to mitigate treatment-related adverse events that may occur during treatment with CAR T-cell therapy
  • Discuss the emerging results of clinical trials that are investigating CAR T-cell therapies in lymphoma and myeloma
  • Optimize the referral process and multidisciplinary care for patients who qualify for CAR T-cell therapy

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Bio Ascend. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Agenda
7:00 PM   
Welcome, Introductions, and Pre-session Survey
7:10 PM   Overview of CAR T-cell Therapy
- CAR T-cell mechanism of action
- Treatment process
7:25 PM   Clinical experience with CAR T-cell therapy for lymphoma and myeloma
- CD19-targeting
- BCMA-targeting
8:05 PM   How to manage novel AE profiles
- Cytokine release syndrome
- Neurotoxicity
8:25 PM   Practical aspects of CAR T-cell therapy
- Choosing the right patient for CAR T-cell therapy
- Optimizing the referral process and multdisciplinary care
8:40 PM   Panel Discussion and Audience Q&A
8:50 PM   Recap of Key Points and Post-session Survey
9:00 PM   Program Adjourns

Chair
Sagar Lonial, MD, FACP
Chief Medical Officer
Professor and Chair, Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Winship Cancer Institute of Emory University
Atlanta, Georgia


Faculty
Loretta Nastoupil, MD
Associate Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine
Director, Lymphoma Outcomes Database, Department of Lymphoma/Myeloma, Division of Cancer Medicine
Section Chief, New Drug Development, Department of Lymphoma/Myeloma, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas

Nina Shah, MD
Associate Professor, Department of Medicine
University of California San Francisco
San Francisco, California

Disclosure of Commercial Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.

Support
This activity is supported by independent educational grants from Janssen and Legend Biotech.


There is no fee to register for this symposium. 
Not an official event of the 2021 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or Conquer Cancer.



Select the Continue button below to register.